Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 726

1.

Goal-oriented monitoring of cyclosporine is effective for graft-versus-host disease prevention after Hematopoietic Stem Cell Transplantation in Sickle Cell Disease and Thalassemia major.

Gauthier A, Bleyzac N, Garnier N, Kebaili K, Joly P, Goutagny MP, Mollet I, Goutelle S, Renard C, Bertrand Y.

Biol Blood Marrow Transplant. 2020 Jan 30. pii: S1083-8791(20)30048-3. doi: 10.1016/j.bbmt.2020.01.016. [Epub ahead of print]

PMID:
32007639
2.

Sialic acids rather than glycosaminoglycans affect normal and sickle red blood cell rheology by binding to four major sites on fibrinogen.

Gondelaud F, Connes P, Nader E, Renoux C, Fort R, Gauthier A, Joly P, Ricard-Blum S.

Am J Hematol. 2020 Jan 5. doi: 10.1002/ajh.25718. [Epub ahead of print] No abstract available.

PMID:
31903639
3.

Impact of A Six Week Training Program on Ventilatory Efficiency, Red Blood Cell Rheological Parameters and Red Blood Cell Nitric Oxide Signaling in Young Sickle Cell Anemia Patients: A Pilot Study.

Grau M, Nader E, Jerke M, Schenk A, Renoux C, Dietz T, Collins B, Bizjak DA, Joly P, Bloch W, Prokop A, Connes P.

J Clin Med. 2019 Dec 5;8(12). pii: E2155. doi: 10.3390/jcm8122155.

4.

Author Correction: B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoid.

Berkani N, Joly P, Golinski ML, Colliou N, Lim A, Larbi A, Riou G, Caillot F, Bernard P, Bedane C, Delaporte E, Chaby G, Dompmartin A, Hertl M, Calbo S, Musette P.

Sci Rep. 2019 Dec 9;9(1):18991. doi: 10.1038/s41598-019-54421-6.

5.

Does in vitro selection of biocontrol agents guarantee success in planta? A study case of wheat protection against Fusarium seedling blight by soil bacteria.

Besset-Manzoni Y, Joly P, Brutel A, Gerin F, Soudière O, Langin T, Prigent-Combaret C.

PLoS One. 2019 Dec 5;14(12):e0225655. doi: 10.1371/journal.pone.0225655. eCollection 2019.

6.

MAPT (mono antiplatelet therapy) as regular regimen after COBRA PzF™ NanoCoated Coronary stent (NCS) implantation.

Maillard L, Vochelet F, Peycher P, Ayari A, Barra N, Billé J, Joly P, Silvestri M, Sévilla J, Tavildari A.

Cardiovasc Revasc Med. 2019 Oct 18. pii: S1553-8389(19)30656-6. doi: 10.1016/j.carrev.2019.10.007. [Epub ahead of print]

PMID:
31780418
7.

Femoral Versus Nonfemoral Peripheral Access for Transcatheter Aortic Valve Replacement.

Beurtheret S, Karam N, Resseguier N, Houel R, Modine T, Folliguet T, Chamandi C, Com O, Gelisse R, Bille J, Joly P, Barra N, Tavildari A, Commeau P, Armero S, Pankert M, Pansieri M, Siame S, Koning R, Laskar M, Le Dolley Y, Maudiere A, Villette B, Khanoyan P, Seitz J, Blanchard D, Spaulding C, Lefevre T, Van Belle E, Gilard M, Eltchaninoff H, Iung B, Verhoye JP, Abi-Akar R, Achouh P, Cuisset T, Leprince P, Marijon E, Le Breton H, Lafont A.

J Am Coll Cardiol. 2019 Dec 3;74(22):2728-2739. doi: 10.1016/j.jacc.2019.09.054.

8.

Impact of a 10 km running trial on eryptosis, red blood cell rheology, and electrophysiology in endurance trained athletes: a pilot study.

Nader E, Monedero D, Robert M, Skinner S, Stauffer E, Cibiel A, Germain M, Hugonnet J, Scheer A, Joly P, Renoux C, Connes P, Égée S.

Eur J Appl Physiol. 2020 Jan;120(1):255-266. doi: 10.1007/s00421-019-04271-x. Epub 2019 Nov 27.

PMID:
31776697
9.

Journées dermatologiques de Paris 2019.

Joly P; Comité de sélection.

Ann Dermatol Venereol. 2019 Dec;146(12S):A1. doi: 10.1016/j.annder.2019.10.017. French. No abstract available.

PMID:
31757228
10.

Blood Rheology: Key Parameters, Impact on Blood Flow, Role in Sickle Cell Disease and Effects of Exercise.

Nader E, Skinner S, Romana M, Fort R, Lemonne N, Guillot N, Gauthier A, Antoine-Jonville S, Renoux C, Hardy-Dessources MD, Stauffer E, Joly P, Bertrand Y, Connes P.

Front Physiol. 2019 Oct 17;10:1329. doi: 10.3389/fphys.2019.01329. eCollection 2019. Review.

11.

Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the FRANCE-TAVI Registry.

Van Belle E, Vincent F, Labreuche J, Auffret V, Debry N, Lefèvre T, Eltchaninoff H, Manigold T, Gilard M, Verhoye JP, Himbert D, Koning R, Collet JP, Leprince P, Teiger E, Duhamel A, Cosenza A, Schurtz G, Porouchani S, Lattuca B, Robin E, Coisne A, Modine T, Richardson M, Joly P, Rioufol G, Ghostine S, Bar O, Amabile N, Champagnac D, Ohlmann P, Meneveau N, Lhermusier T, Leroux L, Leclercq F, Gandet T, Pinaud F, Cuisset T, Motreff P, Souteyrand G, Iung B, Folliguet T, Commeau P, Cayla G, Bayet G, Darremont O, Spaulding C, Le Breton H, Delhaye C.

Circulation. 2020 Jan 28;141(4):243-259. doi: 10.1161/CIRCULATIONAHA.119.043785. Epub 2019 Nov 16.

PMID:
31736356
12.

[Authors response to the letter on the article: "The place of Androcur® in the treatment of diffuse female pattern hair loss"].

Pham AD, Guillot B, Beylot-Barry M, Chosidow O, Reygagne P, Joly P.

Ann Dermatol Venereol. 2019 Dec;146(12):822-823. doi: 10.1016/j.annder.2019.10.016. Epub 2019 Nov 12. French. No abstract available.

PMID:
31732137
13.

Comparison of real costs in the French healthcare system in newly diagnosed patients with pemphigus for first-line treatment with rituximab vs. standard corticosteroid regimen: data from a national multicentre trial.

Hébert V, Vermeulin T, Tanguy L, Tedbirt B, Mignard C, Bénichou J, Joly P.

Br J Dermatol. 2019 Oct 28. doi: 10.1111/bjd.18563. [Epub ahead of print]

PMID:
31657454
14.

[French adaptation of a new score for global assessment of psoriasis severity: The Simplified Psoriasis Index (SPI)].

Richard MA, Aractingi S, Joly P, Mahé E, Auquier P, Le Guen S, Acquadro C, Boucher F, Chalmers RJG.

Ann Dermatol Venereol. 2019 Dec;146(12):783-792. doi: 10.1016/j.annder.2019.08.004. Epub 2019 Oct 14. French.

PMID:
31623858
15.

Genetic Background of β-Thalassemia in Northeast Algeria with Assessment of the Thalassemia Severity Score and Description of a new β0-Thalassemia Frameshift Mutation (HBB: c.374dup; p.Pro126Thrfs*15).

Abdaoui W, Benouareth DE, Djenouni A, Renoux C, Grifi F, Gouri A, Athamnia F, Benalioua M, Joly P.

Hemoglobin. 2019 Jul - Sep;43(4-5):223-228. doi: 10.1080/03630269.2019.1675689. Epub 2019 Oct 11.

PMID:
31603010
16.

[Severe immediate hypersensitivity reaction with generalized contact urticaria after cutaneous application of topical permethrin].

Jelti L, Bauvin O, Joly P, Tetart F.

Ann Dermatol Venereol. 2019 Nov;146(11):720-724. doi: 10.1016/j.annder.2019.08.009. Epub 2019 Oct 7. French.

PMID:
31601439
17.

Methodological aspects of the oxygenscan in sickle cell disease: A need for standardization.

Rab MAE, Kanne CK, Bos J, Boisson C, van Oirschot BA, Nader E, Renoux C, Joly P, Fort R, van Beers EJ, Sheehan VA, van Wijk R, Connes P.

Am J Hematol. 2020 Jan;95(1):E5-E8. doi: 10.1002/ajh.25655. Epub 2019 Oct 26. No abstract available.

18.

Pemphigus.

Schmidt E, Kasperkiewicz M, Joly P.

Lancet. 2019 Sep 7;394(10201):882-894. doi: 10.1016/S0140-6736(19)31778-7. Review.

PMID:
31498102
19.

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect.

Chen DM, Odueyungbo A, Csinady E, Gearhart L, Lehane P, Cheu M, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, Caillot F, Golinski ML, Labeille B, Picard-Dahan C, Paul C, Richard MA, Bouaziz JD, Duvert-Lehembre S, Bernard P, Caux F, Alexandre M, Ingen-Housz-Oro S, Vabres P, Delaporte E, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bedane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Benichou J, Musette P, Joly P; French Study Group on Autoimmune Bullous Diseases.

Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18482. [Epub ahead of print]

PMID:
31487383
20.

Modifications of the Transcriptomic Profile of Autoreactive B Cells From Pemphigus Patients After Treatment With Rituximab or a Standard Corticosteroid Regimen.

Hébert V, Petit M, Maho-Vaillant M, Golinski ML, Riou G, Derambure C, Boyer O, Joly P, Calbo S.

Front Immunol. 2019 Aug 7;10:1794. doi: 10.3389/fimmu.2019.01794. eCollection 2019.

21.

Users of biologics in clinical practice: would they be eligible for phase III clinical studies? Cohort Study in the French Psoriasis Registry PSOBIOTEQ.

Masson Regnault M, Castañeda-Sanabria J, Diep Tran MHT, Beylot-Barry M, Bachelez H, Beneton N, Chosidow O, Dupuy A, Joly P, Jullien D, Mahé E, Richard MA, Viguier M, Tubach F, Sbidian E, Paul C; PsoBioTeq Study Group.

J Eur Acad Dermatol Venereol. 2020 Feb;34(2):293-300. doi: 10.1111/jdv.15878. Epub 2019 Oct 17.

PMID:
31419355
22.

Hyperthyroidism: acquired cause of an increase in haemoglobin A2 level.

Stein E, Gérard D, Joly P, Lesesve JF, Perrin J.

Ann Biol Clin (Paris). 2019 Aug 1;77(4):436-438. doi: 10.1684/abc.2019.1468.

PMID:
31418705
23.

Effect of acute exercise on RBC deformability and RBC nitric oxide synthase signalling pathway in young sickle cell anaemia patients.

Grau M, Jerke M, Nader E, Schenk A, Renoux C, Collins B, Dietz T, Bizjak DA, Joly P, Bloch W, Connes P, Prokop A.

Sci Rep. 2019 Aug 14;9(1):11813. doi: 10.1038/s41598-019-48364-1.

24.

Receptor for Advanced Glycation End Products Antagonism Blunts Kidney Damage in Transgenic Townes Sickle Mice.

Charrin E, Faes C, Sotiaux A, Skinner S, Pialoux V, Joly P, Connes P, Martin C.

Front Physiol. 2019 Jul 23;10:880. doi: 10.3389/fphys.2019.00880. eCollection 2019.

25.

Combined and differential effects of alpha-thalassemia and HbF-quantitative trait loci in Senegalese hydroxyurea-free children with sickle cell anemia.

Gueye Tall F, Martin C, Ndour EHM, Renoux C, Ly ID, Connes P, Gueye PM, Diallo RN, Diagne I, Diop PA, Cissé A, Lopez Sall P, Joly P.

Pediatr Blood Cancer. 2019 Oct;66(10):e27934. doi: 10.1002/pbc.27934. Epub 2019 Jul 19.

PMID:
31322815
26.

Differential effects of adenylyl cyclase-protein kinase A cascade on shear-induced changes of sickle cell deformability.

Ugurel E, Connes P, Yavas G, Eglenen B, Turkay M, Aksu AC, Renoux C, Joly P, Gauthier A, Hot A, Bertrand Y, Cannas G, Yalcin O.

Clin Hemorheol Microcirc. 2019;73(4):531-543. doi: 10.3233/CH-190563.

PMID:
31306111
27.

Transient liver injury and severe neonatal cholestasis in infant with glucose-6-phosphate dehydrogenase deficiency due to a new mutation.

Ben Fredj D, Barro C, Joly P, Thomassin N, Collardeau-Frachon S, Plantaz D, Adjaoud D.

Arch Pediatr. 2019 Sep;26(6):370-373. doi: 10.1016/j.arcped.2019.05.005. Epub 2019 Jul 2.

PMID:
31278024
28.

[Primary central nervous system lymphoma following immunotherapy for metastatic melanoma].

Castel M, Cotten C, Deschamps-Huvier A, Commin MH, Marguet F, Jardin F, Duval-Modeste AB, Joly P.

Ann Dermatol Venereol. 2019 Oct;146(10):634-639. doi: 10.1016/j.annder.2019.04.021. Epub 2019 May 20. French.

PMID:
31122751
29.

Impact of surface-area-to-volume ratio, internal viscosity and membrane viscoelasticity on red blood cell deformability measured in isotonic condition.

Renoux C, Faivre M, Bessaa A, Da Costa L, Joly P, Gauthier A, Connes P.

Sci Rep. 2019 May 1;9(1):6771. doi: 10.1038/s41598-019-43200-y.

30.

Simultaneous long-lasting regression of multiple nevi and melanoma metastases after ipilimumab therapy.

Plaquevent M, Greliak A, Pinard C, Duval-Modeste AB, Joly P.

Melanoma Res. 2019 Jun;29(3):311-312. doi: 10.1097/CMR.0000000000000555.

PMID:
31026247
31.

Regression analysis in an illness-death model with interval-censored data: A pseudo-value approach.

Sabathé C, Andersen PK, Helmer C, Gerds TA, Jacqmin-Gadda H, Joly P.

Stat Methods Med Res. 2019 Apr 16:962280219842271. doi: 10.1177/0962280219842271. [Epub ahead of print]

PMID:
30991888
32.

[Tacrolimus ointment in the management of atopic keratoconjunctivitis].

Benaim D, Tétart F, Bauvin O, Delcampe A, Joly P, Muraine M, Gueudry J.

J Fr Ophtalmol. 2019 May;42(5):435-440. doi: 10.1016/j.jfo.2018.07.018. Epub 2019 Mar 29. French.

PMID:
30935698
33.

[Update of the French recommendations for the management of pemphigus].

Jelti L, Prost-Squarcioni C, Ingen-Housz-Oro S, Caux F, Bernard P, Bedane C, Alexandre M, Dereure O, Quereux G, Le Bidre E, Plée J, Picard-Dahan C, Le Roux-Villet C, Duvert-Lehembre S, Richard MA, Delaporte E, Debarbieux S, Jullien D, D'Incan M, Konstantinou MP, Bouaziz JD, Tancrède-Bohin E, Doutre MS, Bourgault Villada I, Cordel N, Sassolas B, Viguier MA, Mellottée B, Jouen F, Hebert V, Joly P; Centre de référence des maladies bulleuses auto-immunes (MALIBUL); Groupe Bulles de la SFD et la Filière des maladies rares dermatologiques (FIMARAD).

Ann Dermatol Venereol. 2019 Apr;146(4):279-286. doi: 10.1016/j.annder.2019.01.018. Epub 2019 Mar 29. French. No abstract available.

PMID:
30929874
34.

[The place of Androcur® in the treatment of diffuse female pattern hair loss].

Pham AD, Guillot B, Beylot-Barry M, Chosidow O, Reygagne P, Joly P.

Ann Dermatol Venereol. 2019 Apr;146(4):311-312. doi: 10.1016/j.annder.2019.02.008. Epub 2019 Mar 27. French. No abstract available.

PMID:
30926139
35.

The IgG2 Isotype of Anti-Transcription Intermediary Factor 1γ Autoantibodies Is a Biomarker of Cancer and Mortality in Adult Dermatomyositis.

Aussy A, Fréret M, Gallay L, Bessis D, Vincent T, Jullien D, Drouot L, Jouen F, Joly P, Marie I, Meyer A, Sibilia J, Bader-Meunier B, Hachulla E, Hamidou M, Huë S, Charuel JL, Fabien N, Viailly PJ, Allenbach Y, Benveniste O, Cordel N, Boyer O; OncoMyositis Study Group.

Arthritis Rheumatol. 2019 Aug;71(8):1360-1370. doi: 10.1002/art.40895. Epub 2019 Jul 8.

PMID:
30896088
36.

Tacrolimus ointment in the management of atopic keratoconjunctivitis.

Benaim D, Tétart F, Bauvin O, Delcampe A, Joly P, Muraine M, Gueudry J.

J Fr Ophtalmol. 2019 Apr;42(4):e147-e151. doi: 10.1016/j.jfo.2019.02.003. Epub 2019 Mar 7.

PMID:
30851973
37.

B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoid.

Berkani N, Joly P, Golinski ML, Colliou N, Lim A, Larbi A, Riou G, Caillot F, Bernard P, Bedane C, Delaporte E, Chaby G, Dompmartin A, Hertl M, Calbo S, Musette P.

Sci Rep. 2019 Mar 5;9(1):3525. doi: 10.1038/s41598-019-40203-7. Erratum in: Sci Rep. 2019 Dec 9;9(1):18991.

38.

Public perception of dermatologists in France: results from a population-based national survey.

Richard MA, Joly P, Roy Geffroy B, Taïeb C.

J Eur Acad Dermatol Venereol. 2019 Aug;33(8):1610-1615. doi: 10.1111/jdv.15541. Epub 2019 May 17.

PMID:
30835850
39.

Efficacy and safety of oral alitretinoin as treatment for chronic hand eczema in France: a real-life open-label study.

Halioua B, Paul C, Berbis P, Cambazard F, Doutre MS, Joly P, Richard MA, Aubin C, Gruber A, Chosidow O.

Eur J Dermatol. 2019 Feb 1;29(1):59-66. doi: 10.1684/ejd.2018.3484.

PMID:
30827949
40.

Evaluation of agreement between hemoglobin A1c, fasting glucose, and fructosamine in Senegalese individuals with and without sickle-cell trait.

Skinner S, Diaw M, Ndour Mbaye M, Joly P, Renoux C, Masson C, Cuerq C, Lopez P, Ndour M, Diedhiou D, Sow D, Diop S, Samb A, Pialoux V, Connes P.

PLoS One. 2019 Feb 15;14(2):e0212552. doi: 10.1371/journal.pone.0212552. eCollection 2019.

41.

Automatic depletion with Spectra Optia allows a safe 16% reduction of red blood cell pack consumption in exchanged sickle cell anemia patients.

Hequet O, Poutrel S, Connes P, Revesz D, Chelghoum Y, Kebaili K, Cannas G, Gauthier A, Guironnet-Paquet A, Vocanson M, Nicolas JF, Renoux C, Raba M, Cognasse F, Bertrand Y, Hot A, Joly P.

Transfusion. 2019 May;59(5):1692-1697. doi: 10.1111/trf.15188. Epub 2019 Feb 12.

PMID:
30747440
42.

An Additional Case of Hb Saint Nazaire [β103(G5)Phe→Ile; HBB: c.310T>A] Leading to Moderate Erythrocytosis in a French Family.

Bobée V, Feugray G, Brunel V, Joly P, Lahary A.

Hemoglobin. 2019 Jan;43(1):50-51. doi: 10.1080/03630269.2019.1567529. Epub 2019 Jan 30.

PMID:
30700173
43.

Erratum. Increased Prevalence of Type 2 Diabetes-Related Complications in Combined Type 2 Diabetes and Sickle Cell Trait. Diabetes Care 2018;41:2595-2602.

Skinner SC, Diaw M, Pialoux V, Mbaye MN, Mury P, Lopez P, Bousquet D, Gueye F, Diedhiou D, Joly P, Renoux C, Sow D, Diop S, Ranque B, Vinet A, Samb A, Guillot N, Connes P.

Diabetes Care. 2019 Mar;42(3):494. doi: 10.2337/dc19-er03b. Epub 2019 Jan 23. No abstract available.

44.

Linear IgA bullous dermatosis treated with rituximab.

Pinard C, Hebert V, Lecuyer M, Sacre L, Joly P.

JAAD Case Rep. 2019 Jan 12;5(2):124-126. doi: 10.1016/j.jdcr.2018.11.004. eCollection 2019 Feb. No abstract available.

45.

Secular trends of mortality and dementia-free life expectancy over a 10-year period in France.

Grasset L, Pérès K, Joly P, Sabathé C, Foubert-Samier A, Dartigues JF, Helmer C.

Eur J Epidemiol. 2019 Feb;34(2):115-123. doi: 10.1007/s10654-019-00482-w. Epub 2019 Jan 16.

PMID:
30649704
46.

Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma.

Mignard C, Deschamps Huvier A, Gillibert A, Duval Modeste AB, Dutriaux C, Khammari A, Avril MF, Kramkimel N, Mortier L, Marcant P, Lesimple T, Gaudy-Marqueste C, Lesage C, Machet L, Aubin F, Meyer N, Beneton N, Jeudy G, Montaudié H, Arnault JP, Visseaux L, Trabelsi S, Amini-Adle M, Maubec E, Le Corre Y, Lipsker D, Wierzbicka-Hainaut E, Litrowski N, Stefan A, Brunet-Possenti F, Leccia MT, Joly P.

J Oncol. 2018 Dec 2;2018:1908065. doi: 10.1155/2018/1908065. eCollection 2018.

47.

Assessment of liver fibrosis by transient elastography (Fibroscan®) in patients with A1AT deficiency.

Guillaud O, Dumortier J, Traclet J, Restier L, Joly P, Chapuis-Cellier C, Lachaux A, Mornex JF.

Clin Res Hepatol Gastroenterol. 2019 Feb;43(1):77-81. doi: 10.1016/j.clinre.2018.08.016. Epub 2019 Jan 3.

PMID:
30612958
48.

Drepa-Opia: A Pilot Study to Determine the Predictive Factors of Morphine Use and Consumption in Hospitalized Adult Patients with Sickle Cell Disease.

Sabrie M, Cannas G, Tazarourte K, Poutrel S, Connes P, Hot A, Renoux C, Fattoum J, Joly P.

Hemoglobin. 2018 Jul;42(4):217-224. doi: 10.1080/03630269.2018.1529602. Epub 2019 Jan 3.

PMID:
30604640
49.

Liver disease related to alpha1-antitrypsin deficiency in French children: The DEFI-ALPHA cohort.

Ruiz M, Lacaille F, Berthiller J, Joly P, Dumortier J, Aumar M, Bridoux-Henno L, Jacquemin E, Lamireau T, Broué P, Rivet C, Belmalih A, Restier L, Chapuis-Cellier C, Bouchecareilh M, Lachaux A; Groupe Francophone d’Hépatologie Gastroentérologie et Nutrition Pédiatriques.

Liver Int. 2019 Jun;39(6):1136-1146. doi: 10.1111/liv.14035. Epub 2019 Feb 1.

PMID:
30589493
50.

Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General Population.

Plaquevent M, Tétart F, Fardet L, Ingen-Housz-Oro S, Valeyrie-Allanore L, Bernard P, Hebert V, Roussel A, Avenel-Audran M, Chaby G, D'Incan M, Ferrier-Le-Bouedec MC, Duvert-Lehembre S, Picard-Dahan C, Jeudy G, Collet E, Labeille B, Morice C, Richard MA, Bourgault-Villada I, Litrowski N, Bara C, Mahe E, Prost-Squarcioni C, Alexandre M, Quereux G, Bernier C, Soria A, Thomas-Beaulieu D, Pauwels C, Dereure O, Benichou J, Joly P; French Investigators for Skin Adverse Reaction to Drugs; French Study Group on Autoimmune Bullous Skin Diseases.

J Invest Dermatol. 2019 Apr;139(4):835-841. doi: 10.1016/j.jid.2018.10.045. Epub 2018 Dec 10.

PMID:
30543900

Supplemental Content

Support Center